LLMpediaThe first transparent, open encyclopedia generated by LLMs

Calico Life Sciences

Generated by Llama 3.3-70B
⚠Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Google X Hop 3
Expansion Funnel Raw 25 → Dedup 6 → NER 3 → Enqueued 2
1. Extracted25
2. After dedup6 (None)
3. After NER3 (None)
Rejected: 3 (not NE: 3)
4. Enqueued2 (None)
Similarity rejected: 1

Calico Life Sciences. Calico Life Sciences is a biotechnology company focused on aging and longevity research. The company was founded in 2013 as a subsidiary of Alphabet Inc., the parent company of Google. Calico aims to understand the biology of aging and to develop interventions that can help people lead longer and healthier lives. The company's research focuses on genetics, epigenetics, and biomarkers of aging.

Overview

Calico Life Sciences is a research-focused company that aims to develop a deeper understanding of the aging process and to identify potential therapeutic targets for age-related diseases. The company's research is based on the idea that understanding the biology of aging can lead to the development of effective interventions for age-related diseases such as Alzheimer's disease, Parkinson's disease, and cancer. Calico's research approach involves using advanced technologies such as genome editing and single-cell analysis to study the aging process.

History

Calico Life Sciences was founded on September 18, 2013, by Larry Page, Sergey Brin, and Arthur Levinson. The company's early leadership team included Hal Barron, who served as the company's first president and chief scientific officer. In 2014, Calico established a research facility in San Francisco, California, and began collaborating with other research institutions such as the Buck Institute for Research on Aging and the Stanford University School of Medicine.

Research_and_Development

Calico's research and development efforts are focused on understanding the biology of aging and developing interventions that can help people lead longer and healthier lives. The company's research programs include studies on senescence, stem cell biology, and regenerative medicine. Calico is also developing a range of research tools and technologies, including genome editing and single-cell analysis, to support its research programs.

Products_and_Services

Calico Life Sciences is not a product-based company, but rather a research-focused organization that aims to develop a deeper understanding of the aging process. However, the company has developed a range of research tools and technologies, including genome editing and single-cell analysis, that are available to the research community.

Partnerships_and_Collaborations

Calico Life Sciences has established partnerships with a range of research institutions and companies, including the Buck Institute for Research on Aging, the Stanford University School of Medicine, and Biogen. These partnerships aim to accelerate the development of effective interventions for age-related diseases and to advance our understanding of the aging process. Category:Biotechnology companies of the United States